Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

4basebio Plc (4BB) Share Price

Price 1,125.00p on 27-03-2025 at 17:30:01
Change -10.00p -0.88%
Buy 1,150.00p
Sell 1,100.00p
Buy / Sell 4BB Shares
Last Trade: Buy 11.00 at 1,131.00p
Day's Volume: 648
Last Close: 1,125.00p
Open: 1,135.00p
ISIN: GB00BMCLYF79
Day's Range 1,125.00p - 1,135.00p
52wk Range: 930.00p - 1,820.00p
Market Capitalisation: £174m
VWAP: 1,136.0216p
Shares in Issue: 15m

4basebio Plc (4BB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 11 1,131.00p Ordinary
13:05:29 - 27-Mar-25
Buy* 250 1,150.00p Ordinary
11:59:25 - 27-Mar-25
Sell* 379 1,127.00p Ordinary
10:30:47 - 27-Mar-25
Sell* 8 1,133.50p Ordinary
08:30:10 - 27-Mar-25
Buy* 44 1,131.00p Ordinary
09:18:19 - 26-Mar-25
Buy* 1 1,150.00p SI Trade
08:38:58 - 26-Mar-25
Unknown* 0 1,150.00p SI Trade
08:38:58 - 26-Mar-25
Buy* 8 1,150.00p SI Trade
15:18:32 - 25-Mar-25
Buy* 4 1,150.00p SI Trade
15:18:32 - 25-Mar-25
Buy* 2 1,150.00p SI Trade
15:18:32 - 25-Mar-25
See more 4basebio Plc trades

4basebio Plc (4BB) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Mar 2025 (Thu) 1,135.00 1,135.00 1,125.00 1,125.00 648
26th Mar 2025 (Wed) 1,115.00 1,135.00 1,115.00 1,135.00 45
25th Mar 2025 (Tue) 1,120.00 1,170.00 1,115.00 1,115.00 610
24th Mar 2025 (Mon) 1,135.00 1,170.00 1,120.00 1,120.00 567
21st Mar 2025 (Fri) 1,120.00 1,120.00 1,120.00 1,120.00 441
20th Mar 2025 (Thu) 1,120.00 1,120.00 1,120.00 1,120.00 4
19th Mar 2025 (Wed) 1,120.00 1,120.00 1,120.00 1,120.00 73
18th Mar 2025 (Tue) 1,120.00 1,120.00 1,120.00 1,120.00 40
17th Mar 2025 (Mon) 1,120.00 1,150.00 1,120.00 1,150.00 70
14th Mar 2025 (Fri) 1,120.00 1,170.00 1,120.00 1,120.00 292
13th Mar 2025 (Thu) 1,115.00 1,140.00 1,115.00 1,115.00 78
12th Mar 2025 (Wed) 1,115.00 1,115.00 1,115.00 1,115.00 845
11th Mar 2025 (Tue) 1,115.00 1,115.00 1,115.00 1,115.00 632
10th Mar 2025 (Mon) 1,115.00 1,115.00 1,115.00 1,115.00 1,304
7th Mar 2025 (Fri) 1,115.00 1,115.00 1,115.00 1,115.00 1
6th Mar 2025 (Thu) 1,115.00 1,115.00 1,115.00 1,115.00 214
5th Mar 2025 (Wed) 1,115.00 1,115.00 1,115.00 1,115.00 1,443
4th Mar 2025 (Tue) 1,115.00 1,115.00 1,115.00 1,115.00 6
3rd Mar 2025 (Mon) 1,115.00 1,115.00 1,115.00 1,115.00 3
28th Feb 2025 (Fri) 1,120.00 1,160.00 1,160.00 1,160.00 2,477
See more 4basebio Plc price history

4basebio Plc (4BB) Regulatory News

Date Source Headline
25th Mar 2025 10:15 am PRN Holding(s) in Company
14th Mar 2025 7:00 am PRN RBC Capital Markets initiates research coverage
7th Mar 2025 7:00 am PRN Employee Long Term Incentive Plan and Issue of Equity
3rd Mar 2025 4:37 pm PRN Director's Dealing
8th Jan 2025 7:00 am PRN Appointment of Chief Commercial Officer
17th Dec 2024 7:00 am PRN Directorate Change
29th Nov 2024 12:30 pm PRN Director's Dealing
19th Nov 2024 2:15 pm PRN Director's Dealing
15th Nov 2024 5:31 pm PRN Holding(s) in Company
15th Nov 2024 5:30 pm PRN Holding(s) in Company
See more 4basebio Plc regulatory news

4basebio Plc (4BB) Share News

IN BRIEF: 4basebio names Gabe Longoria as new chief commercial officer

8th Jan 2025 11:47

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Names Gabe Longoria as the new chief commercial officer. Longoria was previously CCO at Astrea Bioseparations Ltd. The appointment follows a GBP40 million investment into 4basebio by Elevate Medical Technologies and M&G Investment Management Ltd, which completed in November. This is a "key milestone" for the company. Read More

IN BRIEF: 4basebio to supply synthetic DNA for mRNA vaccine program

10th Apr 2024 11:21

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Announces the supply of its HQ synthetic DNA to an unnamed "Tier 1 pharma company". Says the client will use the synthetic DNA in late preclinical studies for an mRNA vaccine program. Financial details of the contract were not provided by 4basebio. Read More

4basebio updates markets on "key milestone" with client

21st Mar 2024 14:09

(Alliance News) - 4basebio PLC on Thursday noted a "key milestone" with its client, which is progressing into a phase one clinical trial. Read More

TRADING UPDATES: Alpha Real Trust says in "robust" financial shape

1st Mar 2024 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

IN BRIEF: 4basebio wins DNA supply contract to support RNA therapies

1st Mar 2024 14:04

4basebio PLC - Cambridge, England-based life-science tech company with proprietary technologies in the field of DNA synthesis - Announces success in tender process to supply research and GMP-grade synthetic DNA for the development of RNA therapeutics and vaccines at the CPI's RNA Centre of Excellence. The CPI is a UK government-supported organisation which offers development and scale-up services to companies. The Centre for Excellence is the name for its Darlington manufacturing facility. Read More

See more 4basebio Plc news
FTSE 100 Latest
Value8,666.12
Change-23.47

Login to your account

Forgot Password?

Not Registered